Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Jan 29, 2021 10:00 AM - Jan 29, 2021 6:30 PM

8th DIA Cardiac Safety Workshop in Japan

[Session 3]Cardiovascular risk assessment of antitumor drugs

Session Chair(s)

Keita  Fujikawa

Keita Fujikawa

Head of General Medicine, Japan Medical Office

Takeda Pharmaceutical Company Limited, Japan

Yuji  Kumagai, MD, PhD

Yuji Kumagai, MD, PhD

Professor, Kitasato Clinical Research Center

Kitasato University Hospital, Japan

Speaker(s)

Tadahiro  Shinozawa, PhD

Safety translational research for cardio-oncology using iPS cells

Tadahiro Shinozawa, PhD

Takeda Pharmaceutical Company Limited, Japan

Associate Director, Drug Safety Research Lab, Regenerative Medicine Unit

Yoshito  Zamami

Development of preventive treatment against anticancer drug-induced side effects using big data analysis

Yoshito Zamami

Tokushima University Graduate School, Japan

Associate professor, Department of Clinical Pharmacology and Therapeutics,

Hideaki  Takahashi

Cardiovascular risk assessment of antitumor drugs

Hideaki Takahashi

Pharmacheuticals and Medical Devices Agency, Japan

Reviewer

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.